{
    "radiographic_examinations": [
        {
            "procedure_name": "Barium-swallow examination",
            "date": "Not specified",
            "findings": "Narrowing of the distal third of the esophagus, deviation to the left, and smooth mucosa with proximal esophagus dilation.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "CT scan of the chest, abdomen, and pelvis",
            "date": "Not specified",
            "findings": "Heterogeneous soft-tissue mass (4.0 cm) adjacent to the distal esophagus, gastrohepatic and subcarinal lymphadenopathy, and numerous nodules in the right lung.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Combined PET and CT scans",
            "date": "Not specified",
            "findings": "Large metabolically active paraesophageal mass of lymph nodes, increased uptake of 18F-FDG in lymph nodes, multiple scattered lung nodules, focus of 18F-FDG uptake in T1 vertebra, and sclerotic bone lesion in L4 vertebra.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "CT images after crizotinib treatment",
            "date": "12 weeks after the start of crizotinib therapy",
            "findings": "Decreased size of the paraesophageal lymph-node mass and subcarinal lymph nodes.",
            "changes_over_time": "Decreased size of the lesions, overall response meets criteria for a partial response."
        },
        {
            "procedure_name": "Bone scans",
            "date": "Before and after treatment with crizotinib",
            "findings": "Increased radio-tracer uptake in T1 and L4 metastases before treatment.",
            "changes_over_time": "Improvement noted in the T1 and L4 metastases after treatment."
        }
    ]
}